Kiniksa Pharmaceuticals International, plc

KNSA

Kiniksa Pharmaceuticals International, plc is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanj K. Patel, with a market cap of $4.2B.

Market cap

$4.24B+110%

We’re still putting together Kiniksa Pharmaceuticals International, plc’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Earnings

Q1 2026 report

April 28, 2026

Revenue$214.3MBeat by $8.2M EPS$0.27Beat by $0.09

Read the full report

Next report

Jul 28, 2026 (in a month)

Revenue estimate$226.6M

EPS estimate$0.30

Profile

CountryBermuda

Listed2018

Employees297.0

CEOSanj K. Patel

SectorHealthcare

IndustryBiotechnology

Websitekiniksa.com

FilingsSEC EDGAR